SurModics Inc. Reports Q1 Loss
EDEN PRAIRIE, Minn. -- SurModics Inc. (SRDX) today announced a $3.7 million net loss for its fiscal first quarter, ending December 31, 2023. Per share, the Eden Prairie-based company recorded a loss of 26 cents. Excluding one-time costs associated with mergers and acquisitions and amortization, adjusted losses amounted to 4 cents per share.
The drug delivery technology provider reported $29.9 million in revenue for the quarter.
For more information on SRDX stock, access the Zacks investment report at https://www.zacks.com/ap/SRDX.